Company news
Bluenergies Ltd. news in 2010
Bluenergies Ltd.'s news releases, calls and decks from 2010, newest first.
Crystal Research Associates Issues Updated Report on BELLUS Health Inc.
December 16, 2010
Celtic Therapeutics and BELLUS health initiate confirmatory phase III clinical study for KIACTA?, a drug candidate for the treatment of AA amyloidosis
December 15, 2010
BELLUS health reports results for third quarter ended September 30, 2010 and announces receipt of US$5 million from partner celtic therapeutics
November 10, 2010
BELLUS health and FB health enter agreement for BELLUS' VIVIMIND¿ in Italy
October 19, 2010
BELLUS health announces appointment of Martin Tolar, m.d., ph.d. to its board of directors
October 6, 2010
Health Canada grants VIVIMIND¿ a natural health product number
September 30, 2010
Bellus Health reports results for second quarter ended June 30, 2010
August 9, 2010
BELLUS Health Inc.
May 12, 2010
Annual Meeting of Shareholders - BELLUS Health provides update on corporate and product developments
May 12, 2010
BELLUS Health reports results for first quarter ended March 31, 2010
May 12, 2010
BELLUS Health Inc. Annual and Special Meeting of Shareholders May 12, 2010
May 12, 2010
BELLUS Health Inc. Annual and Special Meeting of Shareholders May 12, 2010
May 11, 2010
BELLUS Health ends NC-503 diabetes development program following results
May 4, 2010
BELLUS Health and Celtic Therapeutics enter agreement for BELLUS' drug candidate KIACTA(TM)
April 29, 2010
BELLUS Health announces launch of NRM8499 Phase I clinical study for the treatment of Alzheimer's disease
April 1, 2010
BELLUS Santé annonce le début de l'essai clinique de phase I sur le NRM8499 pour le traitement de la maladie d'Alzheimer
April 1, 2010
BELLUS Health reports results for fourth quarter and year ended December 31, 2009
February 24, 2010
BELLUS Santé annonce ses résultats pour le quatrième trimestre et l'exercice terminés le 31 décembre 2009
February 24, 2010